CVS Health Corporation $CVS Position Raised by Parkwood LLC

Parkwood LLC raised its position in CVS Health Corporation (NYSE:CVS) by 23.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 222,087 shares of the pharmacy operator’s stock after purchasing an additional 42,410 shares during the quarter. CVS Health comprises approximately 1.4% of Parkwood LLC’s investment portfolio, making the stock its 19th biggest holding. Parkwood LLC’s holdings in CVS Health were worth $15,320,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Klingman & Associates LLC acquired a new stake in CVS Health in the 1st quarter valued at approximately $224,000. National Pension Service grew its stake in shares of CVS Health by 5.8% in the first quarter. National Pension Service now owns 3,152,397 shares of the pharmacy operator’s stock worth $213,575,000 after purchasing an additional 173,108 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of CVS Health by 9.4% during the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 38,404 shares of the pharmacy operator’s stock valued at $2,602,000 after purchasing an additional 3,294 shares during the period. Financial Network Wealth Advisors LLC raised its stake in shares of CVS Health by 41.5% during the first quarter. Financial Network Wealth Advisors LLC now owns 989 shares of the pharmacy operator’s stock valued at $67,000 after purchasing an additional 290 shares in the last quarter. Finally, Holderness Investments Co. bought a new position in CVS Health in the 1st quarter valued at about $300,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Up 2.3%

CVS Health stock opened at $80.76 on Friday. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The firm has a market cap of $102.52 billion, a PE ratio of 212.53, a P/E/G ratio of 0.77 and a beta of 0.48. The firm’s 50 day moving average price is $78.93 and its two-hundred day moving average price is $71.71.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. During the same period in the previous year, the company posted $1.09 EPS. CVS Health’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 700.00%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CVS. Baird R W raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. TD Cowen upped their price objective on shares of CVS Health from $99.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, November 3rd. Truist Financial set a $100.00 target price on shares of CVS Health in a research report on Wednesday. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Monday. Finally, Leerink Partners lifted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $93.43.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.